Angela Theresa Amendola, RPAC

Angela Amendola practices at NYU Pathology Associates in New York, New York.

Angela Amendola's NPI, 1447267604, was assigned on August 1, 2006. Angela Amendola holds New York license 006792.

Angela Amendola's primary practice is NYU Pathology Associates, at 530 First Ave Skirball Ste 7n, New York, NY 10016. The practice phone is (212) 263-5475.

Angela Amendola's primary practice is NYU Pathology Associates in New York, New York. Angela Amendola is also affiliated with Tisch Hospital. The medical group on file is NYU Langone Orthopedic Surgery Associates. Dmand AI also links Angela Amendola to 1 more group practice or clinic, named with a free account. Angela Amendola's employer is on file too: a clinical lab.

Dmand AI tracks the electronic health record (EHR) system at each site where Angela Amendola practices, 3 sites in all. Vendor and product names are available with a free account.

Physician assistant is Angela Amendola's primary specialty in the NPI Registry, under taxonomy code 363A00000X. Angela Amendola is licensed in New York.

Dmand AI lists diabetic emergency and vitamin d deficiency among the conditions Angela Amendola treats.

CMS data shows 837 Medicare services from Angela Amendola across 4 procedure codes in 2024, for 159 Medicare patients. Medicare paid $41,199 for them. Every service was in an office.

CMS counts 159 Medicare patients who saw Angela Amendola in 2024. The largest group is 65 to 74, with 65 patients. 75% of them have diabetes, and 75% have high blood pressure. 17% are also on Medicaid. Their average risk score is 2.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Angela Amendola's median patient age at 65, with 49% women.

In 2024, Angela Amendola wrote 2,261 Medicare Part D claims for 270 patients. 27% of them were for generic drugs. CMS names the drug for 1,997 of them, across 43 drugs with 11 or more claims each, at $1,209,413 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Angela Amendola for performance year 2024, reported as part of a group. Angela Amendola accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Angela Amendola as offering telehealth.

CMS Open Payments shows 14 general payments to Angela Amendola from 7 drug and device companies in 2025. Consulting fees make up the largest share, 56% of the total. Sanofi and Genzyme US Companies paid the most, $1,368.